Related Experiment Video
Updated: May 15, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma
J Qi1, J Wang, H Katayama
1Zhongnana Hospital of Wuhan University, Hubei, China.
Abstract:
Incidence and mortality associated with hepatocellular carcinoma (HCC) is rising throughout the world. Accurate, noninvasive biomarkers for the early detection of HCC are urgently needed to reduce worldwide morbidity and mortality related to HCC. MicroRNAs (miRNAs), 17- to 25-nucleotide noncoding RNAs that are frequently dysregulated in HCC, have shown great promise as tissue-based markers for HCC diagnosis and prognosis. Moreover, they are stably expressed in serum and urine, and these circulating microRNAs (cmiRNAs) are emerging as novel noninvasive biomarkers for the early detection and prognosis of HCC. This article summarizes the latest findings on the role of circulating miRNAs as potential minimally invasive diagnostic and prognostic biomarkers for HCC.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs

